GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Owlet Inc (NYSE:OWLT) » Definitions » Debt-to-EBITDA

Owlet (OWLT) Debt-to-EBITDA : 0.83 (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Owlet Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Owlet's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was $10.05 Mil. Owlet's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was $3.85 Mil. Owlet's annualized EBITDA for the quarter that ended in Mar. 2025 was $16.70 Mil. Owlet's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2025 was 0.83.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Owlet's Debt-to-EBITDA or its related term are showing as below:

OWLT' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -3.5   Med: -0.55   Max: -0.21
Current: -1.35

During the past 5 years, the highest Debt-to-EBITDA Ratio of Owlet was -0.21. The lowest was -3.50. And the median was -0.55.

OWLT's Debt-to-EBITDA is ranked worse than
100% of 459 companies
in the Medical Devices & Instruments industry
Industry Median: 1.48 vs OWLT: -1.35

Owlet Debt-to-EBITDA Historical Data

The historical data trend for Owlet's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Owlet Debt-to-EBITDA Chart

Owlet Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-EBITDA
-3.50 -0.39 -0.21 -0.55 -1.24

Owlet Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.72 -1.67 -0.71 -0.39 0.83

Competitive Comparison of Owlet's Debt-to-EBITDA

For the Medical Devices subindustry, Owlet's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Owlet's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Owlet's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Owlet's Debt-to-EBITDA falls into.


;
;

Owlet Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Owlet's Debt-to-EBITDA for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(7.366 + 4.331) / -9.471
=-1.24

Owlet's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2025 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(10.052 + 3.846) / 16.704
=0.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2025) EBITDA data.


Owlet  (NYSE:OWLT) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Owlet Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Owlet's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Owlet Business Description

Traded in Other Exchanges
N/A
Address
2940 West Maple Loop Drive, Suite 203, Lehi, UT, USA, 84043
Owlet Inc is engaged in providing a digital parenting platform that aims to give parents real-time data and insights to help parents feel more calm and confident. Its diversified portfolio of products includes Owlet Smart Sock, the first baby monitor to track an infant's oxygen levels, heart rate, and sleep trends; the Owlet Cam, which turns any smartphone into a baby monitor with high-definition clarity; the Owlet Monitor Duo, which offers the intelligence of the Owlet Smart Sock paired with the Owlet Cam; and Owlet Dream Lab, an interactive online program designed to be a parent's guide to building healthy sleep habits for their infants.
Executives
Jonathan Harris officer: President & CRO 3000 CLEARVIEW WAY, SAN MATEO CA 94402
Kurt Workman director, officer: Chief Executive Officer C/O OWLET, INC., 2500 EXECUTIVE PARKWAY, SUITE 500, LEHI UT 84043
Kathryn R. Scolnick officer: Chief Financial Officer 3300 N ASHTON BLVD, STE 300, LEHI UT 84043
Marc F Stoll director C/O ARISTA NETWORKS, INC., 5453 GREAT AMERICA PARKWAY, SANTA CLARA CA 95054
Melissa Gonzales director C/O OWLET, INC., 3300 NORTH ASHTON BOULEVARD, SUITE 300, LEHI UT 84043
Jason Knafel director 514 HIGH STREET, PALO ALTO CA 94301
Eclipse Early Growth Fund I, L.p. 10 percent owner 514 HIGH STREET, SUITE 4, PALO ALTO CA 94301
Eclipse Early Growth Gp I, Llc 10 percent owner 514 HIGH STREET, SUITE 4, PALO ALTO CA 94301
Trilogy Equity Partners, Llc 10 percent owner 155 108TH AVE NE, SUITE 400, BELLEVUE WA 98004
Michael P. Abbott director, officer: President C/O OWLET, INC., 2500 EXECUTIVE PARKWAY, SUITE 500, LEHI UT 84043
Nathaniel Yoo officer: Chief Accounting Officer C/O OWLET, INC., 2500 EXECUTIVE PARKWAY, SUITE 500, LEHI UT 84043
Eclipse Continuity Fund I, L.p. 10 percent owner 514 HIGH STREET, SUITE 4, PALO ALTO CA 94301
Zane M Burke director C/O LIVONGO HEALTH, INC., 150 WEST EVELYN AVENUE, SUITE 150, MOUNTAIN VIEW CA 94041
John C. Kim director C/O OWLET, INC., 2500 EXECUTIVE PARKWAY, SUITE 500, LEHI UT 84043
Amy Nam Mccullough director C/O OWLET, INC., 2500 EXECUTIVE PARKWAY, SUITE 500, LEHI UT 84043